Wednesday, December 17, 2025 | 02:00 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Anupam Rasayan plans to raise Rs 800 crore through IPO later this year

Incorporated in 1977, Anupam Rasayan caters to market segments spanning agrochemicals, anti-bacterial, polymers, pharmaceuticals, and material sciences

IPO, markets
premium

According to a November 2018 CRISIL report, ARIL has an established market position in the specialty chemical business, backed by a healthy product portfolio, strong clientele, and long-term contract manufacturing agreements.

Ashley Coutinho Mumbai
Specialty chemicals firm Anupam Rasayan (ARIL) plans to tap the market for an initial public offering (IPO) later this year, said two people familiar with the matter. They said the firm plans to raise Rs 600-800 crore and has appointed three investment bankers — Axis Capital, JM Financial, and IIFL — to manage the share sale. An email sent to the company, however, did not elicit a response.
 
Incorporated in 1977, ARIL caters to market segments spanning agrochemicals, anti-bacterial, polymers, pharmaceuticals, and material sciences. The firm clocked revenues of Rs 349 crore for financial year 2017-18 (FY18), with a